COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,357 Articles (22,803 medRxiv, 8,554 bioRxiv)

Most recent first Previous |  Page 728: Articles 7271-7280  | Next

Impact of SARS-Cov-2 on Clinical Trial Unit workforce in the United Kingdom; An observational study
Delanerolle, G., Hu, J., Cavalini, H., Yardley, L., Barnard-Kelly, K., Elliot, K., Raymont, V., Rathod, S., Shi, J. Q., Phiri, P.
10.1101/2022.06.30.22277052 — Posted: 2022-07-03
MENTAL STATUS OVERVIEW IN THE ELDERLY DURING THE COVID-19 PANDEMIC: A PHYLOSOPHICAL PERSPECTIVE
Andriani, A., Lio, F., Saleh, A., Fiqri, A. M.
10.1101/2022.06.30.22277080 — Posted: 2022-07-03
Online grocery shopping during the COVID-19 pandemic - perspectives of adolescents and young adults
Brandt, E. J., Hadler, N., Locher, I., Hoffs, C. T., Waselewski, M. E., Chang, T.
10.1101/2022.06.30.22277101 — Posted: 2022-07-03
Multiple effects of TNFα inhibitors on the development of the adaptive immune response after SARS-CoV-2 vaccination
Geisen, U. M., Rose, R., Neumann, F., Ciripoi, M., Vullriede, L., Reid, H. M., Berner, D. K., Bertoglio, F., Hoff, P., Hust, M., Longardt, A. C., Lorentz, T., Rios Martini, G., Saggau, C., Schirmer, J. H., Schubert, M., Suembuel, M., Tran, F., Voss, M., Zeuner, R., Morrison, P. J., Bacher, P., Fickenscher, H., Gerdes, S., Peipp, M., Schreiber, S., Krumbholz, A., Hoyer, B. F.
10.1101/2022.07.01.22277143 — Posted: 2022-07-03
Phase 2 randomised placebo-controlled trial of spironolactone and dexamethasone versus dexamethasone in COVID-19 hospitalised patients in Delhi
Wadhwa, B., Malhotra, V., Kerai, S., Husain, F., Pandey, N. B., Saxena, K. N., Singh, V., Quinn, T. M., Li, F., Gaughan, E., Shankar-Hari, M., Mills, B., Antonelli, J., Bruce, A., Finlayson, K., Moore, A., Dhaliwal, K., Edwards, C.
10.1101/2022.07.01.22277163 — Posted: 2022-07-02
Self-Reported Use of COVID-19 Immunologic Test Results to Inform Decisions About Daily Activities and COVID-19 Vaccination
Jiang, M., Akers, N. K., Gill, D. B., Eckhert, B., Svejnoha, E., Robins, H. S.
10.1101/2022.07.01.22277108 — Posted: 2022-07-02
The changing landscape of respiratory viruses contributing to respiratory hospitalisations: results from a hospital-based surveillance in Quebec, Canada, 2012-13 to 2021-22
Gilca, R., Amini, R., Carazo, S., Frenette, C., Boivin, G., Charest, H., Dumaresq, J.
10.1101/2022.07.01.22277061 — Posted: 2022-07-02
DIFFERENTIAL SARS-COV-2 ANTIGEN SPECIFICITY OF THE HUMORAL RESPONSE IN INACTIVATED VIRUS-VACCINATED, CONVALESCENT, AND BREAKTHROUGH SUBJECTS
Duarte, L. F., Vasquez, Y., Diethelm-Varela, B., Pavez, V., Berrios-Rojas, R., White, J. A., Kalergis, A. M., Bueno, S. M., Gonzalez, P. A.
10.1101/2022.07.01.22277165 — Posted: 2022-07-02
Pre-existing population immunity and SARS-CoV-2 variant establishment and dominance dynamics in the United States: An ecological study
Ankomah, P. O., Siedner, M., Bhattacharyya, R.
10.1101/2022.07.01.22277157 — Posted: 2022-07-02
Uncertainty and error in SARS-CoV-2 epidemiological parameters inferred from population-level epidemic models
Whittaker, D. G., Herrera-Reyes, A. D., Hendrix, M., Owen, M. R., Band, L. R., Mirams, G. R., Bolton, K. J., Preston, S. P.
10.1101/2022.07.01.22277134 — Posted: 2022-07-02

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).